Shepard CW, Simard EP, Finelli L, Fiore AE, Bell PB, 2006. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112–125.
World Health Organization, 2002. Hepatitis B. Geneva: World Health Organization.
Echevarria JM, Leon P, 2003. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica 19: 1583–1591.
Casey JL, Niro GA, Engle RE, Vega A, Gomez H, McCarthy M, Watts DM, Hyams KC, Gerin JL, 1996. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis 174: 920–926.
Cabezas C, Gotuzzo E, Escamilla J, Phillips I, 1994. Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru. Rev Gastroenterol Peru 14: 123–134.
Farfan G, Cabezas C, 2002. Mortality due to digestive and hepatobiliary diseases in Peru, 1995–2000. Rev Gastroenterol Peru 22: 310–323.
Ruiz E, Almonte MM, Pizarro R, Celis J, Montalbelti JA, Urbano R, 1998. Hepatitis B and C virus infection as risk factors for hepatocarcinoma in Peru: case and control study. Rev Gastroenterol Peru 18: 199–212.
Indacochea S, Bueno R, De La Fuente J, Ferrufino JC, 1997. Liver cancer in hyperendemic area of B and deltahepatitis: report of 19 cases. Rev Gastroenterol Peru 17: 56–59.
Barham WB, Figueroa R, Phillips IA, Hyams KC, 1994. Chronic liver disease in Peru: role of viral hepatitis. J Med Virol 42: 129–132.
Indocochea S, Gotuzzo E, 1993. Mortality due to viral hepatitis B in Abancay. Rev Gastroenterol Peru 13: 173–177.
Alter MJ, Margolis HS, 1990. The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am 74: 1529–1541.
Atkins M, Nolan M, 2005. Sexual transmission of hepatitis B. Curr Opin Infect Dis 18: 67–72.
Heathcote J, Gateau P, Sherlock S, 1974. Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. Lancet 17: 370–371.
Lama JR, Lucchetti A, Suarez L, Laguna-Torres VA, Guanira JV, Pun M, Montano SM, Celum CL, Carr JK, Sanchez J, Bautista CT, Sanchez JL, 2006. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis 194: 1459–1466.
Cabezas C, 2007. Viral hepatitis B and delta in Peru: epidemiology and basis for control. Rev Peru Med Exp Salud Publica 2007: 378–397.
Jin F, Prestage GP, Zablotska I, Rawstorne P, Kippax SC, Donovan B, Cunningham PH, Templeton DJ, Kaldor JM, Grulich AE, 2007. High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sex Transm Infect 83: 397–399.
Koike K, Kikuchi Y, Kato M, Takamatsu J, Shintani Y, Tsutsumi T, Fujie H, Miyoshi H, Moriya K, Yotsuyanagi H, 2007. Prevalence of hepatitis B virus infection in Japanese patients with HIV. Hepatol Res 38: 310–314.
Seage GR, Mayer KH, Lenderking WR, Wold C, Gross M, Goldstein R, Cai B, Heeren T, Hingson R, Holmberg S, 1997. HIV and hepatitis B infection and risk behavior in young gay and bisexual men. Public Health Rep 112: 158–167.
Stroffolini T, Corona R, Giglio A, Gentili G, Caprilli F, Prignano G, Tosti ME, Pasquini P, Mele A, 1997. Risk factors for hepatitis B virus infection among homosexual men attending a sexually transmitted diseases clinic in Italy. New Microbiol 20: 333–338.
Osella AR, Massa MA, Joekes S, Blanch N, Yacci MR, Centonze S, Sileoni S, 1998. Hepatitis B and C virus sexual transmission among homosexual men. Am J Gastroenterol 93: 49–52.
Christiansen MA, Lowhagen GB, 2000. Sexually transmitted diseases and sexual behavior in men attending an outpatients' clinic for gay men in Gothenburg, Sweden. Acta Derm Venereol 80: 136–139.
Diamond C, Thiede H, Perdue T, Secura GM, Valleroy L, Mackellar D, Corey L, 2003. Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination. Sex Transm Dis 30: 425–432.
Marino R, Minichiello V, Disogra C, 2003. Male sex workers in Cordoba, Argentina: sociodemographic characteristics and sex work experiences. Rev Panam Salud Publica 13: 311–319.
Choi KH, McFarland W, Neilands TB, Nguyen S, Secura G, Behel S, Mackellar D, Valleroy L, 2005. High level of hepatitis B infection and ongoing risk among Asian/Pacific Islander men who have sex with men, San Francisco, 2000–2001. Sex Transm Dis 32: 44–48.
Pando MA, Bautista CT, Maulen S, Duranti R, Marone R, Rey J, Vignoles M, Eirin ME, Biglione MM, Griemberg G, Montano SM, Carr JK, Sanchez JL, Avila MM, 2006. Epidemiology of human immunodeficiency virus, viral hepatitis (B and C), Treponema pallidum, and human T-cell lymphotropic I/II virus among men who have sex with men in Buenos Aires, Argentina. Sex Transm Dis 33: 307–313.
Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller IV, 1997. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11: 597–606.
Sulkowski MS, 2008. Viral hepatitis and HIV coinfection. J Hepatol 48: 353–367.
McMahon BJ, 2005. Epidemiology and natural history of hepatitis B. Semin Liver Dis 25: S3–S8.
Hijar J, Suarez M, Padilla C, Cabezas C, 2007. Genotyping of hepatitis B virus in patients of endemic areas from Peru. Rev Peru Med Exp Salud Publica 24: 427–430.
Graham D, McClean H, 2007. Yorkshire regional audit of hepatitis B vaccination. Int J STD AIDS 18: 212–214.
Warwick Z, Dean G, Carter P, 2007. B safe, B sorted: results of a hepatitis B vaccination outreach programme. Int J STD AIDS 18: 335–337.
Sethi G, Holden BM, Greene L, Gaffney J, Ward H, 2006. Hepatitis B vaccination for male sex workers: the experience of a specialist GUM service. Sex Transm Infect 82: 84–85.
Collier AC, Corey L, Murphy VL, Handsfield HH, 1998. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109: 101–105.
Keet IP, van Doornum G, Safary A, Coutinho RA, 1992. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS 6: 509–510.
Yee LJ, Rhodes SD, 2002. Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned? Sex Transm Infect 78: 374–377.
Rudy ET, Detels R, Douglas W, Greenland S, 2003. Factors affecting hepatitis vaccination refusal at a sexually transmitted disease clinic among men who have sex with men. Sex Transm Dis 30: 411–418.
McMillan A, 2005. Hepatitis B vaccination of men who have sex with men: experience with an accelerated course of vaccination in a genitourinary medicine clinic. Int J STD AIDS 6: 633–635.
Gunn RA, Lee MA, Murray PJ, Gilchick RA, Margolis HS, 2007. Hepatitis B vaccination of men who have sex with men attending an urban STD clinic: impact of an ongoing vaccination program, 1998–2003. Sex Transm Dis 34: 663–668.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 2 | 2 | 2 |
Full Text Views | 444 | 177 | 4 |
PDF Downloads | 145 | 48 | 3 |
To assess the epidemiology of hepatitis B virus (HBV) infection among men who have sex with men (MSM) in Peru, we evaluated the prevalence and associated risk factors for HBV serologic markers among participants of a HIV sentinel surveillance conducted in 2002–2003. The standardized prevalences for total antibodies to hepatitis B core antigen (anti-HBc) and hepatitis B surface antigen (HBsAg) were 20.2% and 2.8%, respectively. Individuals with human immunodeficiency virus (HIV-1) infection had significantly higher anti-HBc (44.3% versus 19.3%) and HBsAg (9.5% versus 2.3%) prevalences than uninfected men. Increasing age (adjusted odds ratio [AOR] = 1.06), versatile sexual role (AOR = 1.59), sex in exchange for money/gifts (AOR = 1.58), syphilis (AOR = 1.74), HIV-1 infection (AOR = 1.64), and herpes simplex virus type 2 (HSV-2, AOR = 2.77) infection were independently associated with anti-HBc positivity, whereas only HIV-1 infection (AOR = 3.51) and generalized lymph node enlargement (AOR = 3.72) were associated with HBsAg positivity. Pre-existing HBV infection is very common among Peruvian MSM and was correlated with sexual risk factors. MSM in Peru constitute a target population for further HBV preventive and treatment interventions.
Authors' addresses: Javier R. Lama, Juan V. Guanira, Carmela Ganoza, and Jorge Sanchez, Asociacion Civil Impacta Salud y Educacion, Lima, Peru, E-mails: jrlama@impactaperu.org, jguanira@impactaperu.org, cganoza@impactaperu.org, and jsanchez@impactaperu.org. Hellen S. Agurto, Clinica de Dia Avendaño, Lima, Peru, E-mail: hellenagurto@hotmail.com. Martin Casapia, Asociacion Civil Selva Amazonica, Iquitos, Loreto, Peru, E-mail: mcasapia@acsaperu.org. Nora Ojeda, Asociacion de Servicios Generales de Salud y Educacion, Piura, Peru, E-mail: nojeda02@gmail.com. Abner Ortiz, Asociacion Civil Cayetano Heredia, Ucayali, Peru, E-mail: abnerortizrocca@yahoo.es. Victoria Zamalloa, Instituto Sur Peruano de Infectologia, Arequipa, Peru, E-mail: vzamalloat@gmail.com. Luis Suarez-Ognio, General Directorate of Epidemiology, Ministry of Health of Peru, Lima, Peru, E-mail: lsuarez@dge.gob.pe. Cesar Cabezas, National Institute of Health, Ministry of Health of Peru, Lima, Peru, E-mail: ccabezas@ins.gob.pe. Jose L. Sanchez, Division of GEIS Operations, Armed Forces Health Surveillance Center and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Silver Spring, MD, E-mail: toti.sanchez@us.army.mil.